Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoVacHGMix Phase I in Healthy Volunteers
NCT05526183Phase 1Unknown
- Sponsor
- Ankara City Hospital
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CoVacHGMix in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ankara City Hospital. Primary endpoint: Incidence of Adverse Events. Status: unknown.
02
Drugs
CoVacHGMix
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05526183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05526183.